Breaking News Instant updates and real-time market news.

ATRS

Antares Pharma

$2.63

-0.05 (-1.87%)

04:55
07/11/18
07/11
04:55
07/11/18
04:55

Antares Pharma management to meet with Jefferies

Meeting to be held in Boston on July 11 hosted by Jefferies.

  • 11

    Jul

ATRS Antares Pharma
$2.63

-0.05 (-1.87%)

10/23/17
MSCO
10/23/17
NO CHANGE
Target $26
MSCO
Overweight
Antares CRL should have limited read through to Amag, says Morgan Stanley
After Antares Pharma (ATRS) announced that it has received a FDA complete response letter about the new drug application for Xyosted due to two deficiencies related to clinical data, Morgan Stanley analyst Thomas Smith said the CRL should have limited read through to Amag Pharmaceuticals (AMAG), which has partnered with Antares for technology being used in subcutaneous Makena. The CRL is not related to the device or manufacturing, noted Smith, who adds that investor relief over the minimal Makena read through could lead to a rally in Amag shares following the recent weakness. He keeps 60% probability of success for Makena SC and maintains an Overweight rating on Amag shares.
10/23/17
RAJA
10/23/17
NO CHANGE
Target $3.4
RAJA
Strong Buy
Antares Pharma maintained as a Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur said the FDA's CRL on Antares Pharma (ATRS) XYOSTED was an unexpected and significant setback, but weakness in shares since the October disclosure effectively prices XYOSTED at zero, and substantially undervalues other development programs, especially ANDA products with Teva (TEVA). Wilbur is not writing-off XYSTED yet and is pushing out an expected launch to 2H19 from early 2018 previously, and is now discounting the probability of success at 50% versus 100% prior to the CRL. The analyst maintains asset values for Antares' non-XYOSTED assets are worth $2.50 per share using a sum-of-the-parts valuation and adjusted his price target to $3.40 from $4.20 on shares. Wilbur maintains a Strong Buy rating on Antares
10/23/17
JANY
10/23/17
NO CHANGE
JANY
Neutral
Antares CRL doesn't raise issues for Amag Pharmaceuticals, says Janney Capital
Janney Capital analyst Ken Trbovich noted that the FDA complete response letter issued to Antares (ATRS) for Xyosted did not pertain to the Quickshot subcutaneous autoinjector, which raises his confidence the FDA will not identify such issues as a short coming of the sNDA for Amag Pharmaceuticals' (AMAG) Makena SQ. However, he keeps a Neutral rating on Amag shares, noting that the primary uncertainty for the sNDA for Makena SQ is the fact that its peak plasma levels is higher than the upper bound the FDA uses to define bioequivalence.
05/08/18
HCWC
05/08/18
NO CHANGE
Target $4
HCWC
Buy
Antares target raised to $4 on higher Xyosted confidence at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat said that Antares Pharma reported "solid" Q1 results but "most importantly...finally explicitly confirmed a key aspect of the Xyosted filing," specifically that the company already conducted an ambulatory blood pressure monitoring study as part of the supplemental safety study ahead of the NDA submission. That fact, along with Antares' ability to re-submit the NDA just a week after receiving the minutes from the FDA Type-A meeting, increases his confidence in Xyosted approval coming in 2018, Livnat said. He raised his view of Xyosted's probability of success to 70% from 40% and increased his price target to $4 from $3.50 on Antares shares. Livnat keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$37.33

-0.03 (-0.08%)

16:26
07/20/18
07/20
16:26
07/20/18
16:26
Hot Stocks
FDA approves Pfizer's Biosimilar NIVESTYM for all indications »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

JCP

J.C. Penney

$2.50

-0.065 (-2.53%)

16:23
07/20/18
07/20
16:23
07/20/18
16:23
Hot Stocks
J.C. Penney chief customer officer McFarland to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
07/20/18
07/20
16:20
07/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for July 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$3.15

-0.1 (-3.08%)

16:18
07/20/18
07/20
16:18
07/20/18
16:18
Hot Stocks
Asta Funding receives Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/20/18
07/20
16:17
07/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/20/18
07/20
16:16
07/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

16:15
07/20/18
07/20
16:15
07/20/18
16:15
Periodicals
Disney fires 'Guardians' director after controversial tweets, THR says »

Disney has fired James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

, GE

General Electric

16:15
07/20/18
07/20
16:15
07/20/18
16:15
General news
Fly Intel: Wall Street's top stories for Friday »

Stocks began the day…

MSFT

Microsoft

GE

General Electric

HON

Honeywell

PAH

Platform Specialty Products

GSK

GlaxoSmithKline

PTCT

PTC Therapeutics

LLNW

Limelight Networks

VFC

VF Corp.

SKX

Skechers

STT

State Street

SWKS

Skyworks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 04

    Sep

MYL

Mylan

$35.57

-0.08 (-0.22%)

, AGN

Allergan

$171.85

-1.53 (-0.88%)

16:12
07/20/18
07/20
16:12
07/20/18
16:12
Hot Stocks
PTAB rules in favor of Mylan to allow Restasis challenge to proceed »

Mylan (MYL) announced…

MYL

Mylan

$35.57

-0.08 (-0.22%)

AGN

Allergan

$171.85

-1.53 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Nov

CEI

Camber Energy

$0.45

-0.0236 (-5.03%)

16:07
07/20/18
07/20
16:07
07/20/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Camber Energy  »

Discover Growth Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JONE

Jones Energy

$0.38

-0.0117 (-3.02%)

16:06
07/20/18
07/20
16:06
07/20/18
16:06
Hot Stocks
Jones Energy names Carl Giesler, Jr. CEO »

Jones Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$87.26

-0.14 (-0.16%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Periodicals
Third Point looking into new PayPal investment, Dealreporter says »

Third Point is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 15

    Aug

  • 16

    Aug

BLK

BlackRock

$502.28

-2.15 (-0.43%)

16:01
07/20/18
07/20
16:01
07/20/18
16:01
Hot Stocks
BlackRock CEO Fink discloses sale of $10.1M in stock »

BlackRock CEO Laurence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$93.33

4.12 (4.62%)

15:50
07/20/18
07/20
15:50
07/20/18
15:50
Options
Defensive option play in VF Corp as shares spike on earnings »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BAC

Bank of America

$30.06

0.4 (1.35%)

15:40
07/20/18
07/20
15:40
07/20/18
15:40
Options
Biggest option block of the day is in Bank of America »

Biggest option block of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$41.82

1.125 (2.76%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Periodicals
GSK tells Bloomberg three business structure offers 'significant opportunities' »

Glaxosmithkline told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GE

General Electric

$13.14

-0.59 (-4.30%)

15:30
07/20/18
07/20
15:30
07/20/18
15:30
Options
Heavy trading in GE options as shares face renewed selling pressure »

Heavy trading in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

WSM

Williams-Sonoma

$61.73

-1.01 (-1.61%)

15:25
07/20/18
07/20
15:25
07/20/18
15:25
Options
Williams Sonoma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$322.13

2.46 (0.77%)

15:24
07/20/18
07/20
15:24
07/20/18
15:24
Periodicals
Lockheed Martin's F-35 to play bigger role in Europe defense, Reuters says »

U.S. and European defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:20
07/20/18
07/20
15:20
07/20/18
15:20
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 Index…

IWM

iShares Trust Russell 2000 Index Fund

$168.82

-0.32 (-0.19%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
07/20/18
07/20
15:20
07/20/18
15:20
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TCF

TCF Financial

$25.35

-0.05 (-0.20%)

15:18
07/20/18
07/20
15:18
07/20/18
15:18
Hot Stocks
TCF Bank enters BFCP settlement with CFPB to resolve litigation »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
07/20/18
07/20
15:17
07/20/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
07/20/18
07/20
15:16
07/20/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

15:09
07/20/18
07/20
15:09
07/20/18
15:09
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX), at…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.90

-0.05 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.